How is Follistatin 344 administered?
This describes how Follistatin 344 is typically administered in clinical and research references, not a self-administration guide. The usual route is Subcutaneous, on a daily schedule, generally over 10-30 days max. Specific dosing is individual and beyond general information, and human evidence for Follistatin 344 is limited.
Administration at a glance (reference data)
- Route: Subcutaneous
- Schedule: Daily
- Cycle length: 10-30 days max
- Half-life: ~hours (poorly characterized)
References
- Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors — Haidet AM, Rizo L, Handy C, et al. (incl. Mendell JR, Kaspar BK), PNAS, 2008
- Follistatin gene delivery enhances muscle growth and strength in nonhuman primates — Kota J, Handy C, Haidet AM, et al. (incl. Kaspar BK), Science Translational Medicine, 2009
- A phase 1/2a follistatin gene therapy trial for Becker muscular dystrophy — Mendell JR, et al., Molecular Therapy, 2015 (NCT01519349)
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Follistatin 344
Last updated 2026-06-15.